Skip to main content
NewslettersWatchlist

Cumberland Pharmaceu(CPIX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Cumberland Pharmaceu

1600 WEST END AVENUE SUITE 1300
NASHVILLE TN 37203 USA
P: 615-255-0068
F: 615-255-0094
http://www.cumberlandpharma.com

Sectors & Indices

Sector
Industry
Employees

Profile

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.

Key Executives

NameTitle
A. J. KazimiCEO/Chairman of the Board/Director/Founder
James L. HermanChief Compliance Officer/Senior VP
John M. HammCFO/Chief Accounting Officer/Other Corporate Officer/Vice President
Todd M. AnthonyVice President, Divisional
Chris T. BittermanVice President, Divisional

More from The Globe

number cruncher
U.S technology stocks with earnings and price momentum
For Number Cruncher column in Globe Investor/ROB only.
Lightspeed Commerce stock soars on better-than-expected profit forecast
Lightspeed Commerce Inc. CEO Dax Dasilva poses in the company's offices in Montreal, Wednesday, May 8, 2024. THE CANADIAN PRESS/Christinne Muschi
GameStop, AMC continue to slide as meme stocks rally loses steam
A screen displays the trading information for GameStop and AMC Theatres on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 15.
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
Shopify offices in Toronto on May 13, 2024. May 13, 2024. (Sammy Kogan/The Globe and Mail)
The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
Chevron tops Tesla as most-shorted stock in April, says Hazeltree
The Chevron Pascagoula Refinery is pictured in Pascagoula, Mississippi on Sept. 4, 2018.
The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.